Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Quality of life and symptom end points in palliative bone metastases trials.

Literature DB >> 16477922

Quality of life and symptom end points in palliative bone metastases trials.

E Chow, P Hoskin, Y van der Linden, A Bottomley, G Velikova.

Abstract

Entities: Disease

Mesh：

Year: 2006 PMID： 16477922 DOI： 10.1016/j.clon.2005.06.016

Source DB: PubMed Journal: Clin Oncol (R Coll Radiol) ISSN： 0936-6555 Impact factor: 4.126

Keyword Cloud
Cited

× No keyword cloud information.

9 in total

1. Physician preferences for bone metastasis drug therapy in Canada.

Authors: J Arellano; J M González; Y Qian; M Habib; A F Mohamed; F Gatta; A B Hauber; J Posner; N Califaretti; E Chow
Journal: Curr Oncol Date: 2015-10 Impact factor: 3.677

2. Incidence and outcome of bone metastatic disease at University Malaya Medical Centre.

Authors: Vivek Ajit Singh; Amber Haseeb; Alla Allden H Ali Alkubaisi
Journal: Singapore Med J Date: 2014-10 Impact factor: 1.858

Review 3. Image-guided ultrasound phased arrays are a disruptive technology for non-invasive therapy.

Authors: Kullervo Hynynen; Ryan M Jones
Journal: Phys Med Biol Date: 2016-08-05 Impact factor: 3.609

4. Utilization of agents to prevent skeletal-related events among patients with multiple myeloma: analysis of real-world data.

Authors: Yi Qian; Debajyoti Bhowmik; Nandita Kachru; Rohini K Hernandez; Paul Cheng; Alexander Liede
Journal: Support Care Cancer Date: 2017-10-23 Impact factor: 3.603

9. Distal Medullary Canal Decompression in Long Stem Hip Replacement in Long Bone Metastasis: Does it Reduce Cardiopulmonary Complications?

Authors: Vivek Ajit Singh; Siamak Sarrafan; Ramesh Singh Veriah
Journal: Indian J Orthop Date: 2018 Jan-Feb Impact factor: 1.251

9 in total

Quality of life and symptom end points in palliative bone metastases trials.

1. Physician preferences for bone metastasis drug therapy in Canada.

2. Incidence and outcome of bone metastatic disease at University Malaya Medical Centre.

Review 3. Image-guided ultrasound phased arrays are a disruptive technology for non-invasive therapy.

4. Utilization of agents to prevent skeletal-related events among patients with multiple myeloma: analysis of real-world data.

5. Uterine C-Kit positive low grade stromal sarcoma.

6. Physicians' preferences for bone metastases treatments in France, Germany and the United Kingdom.

Review 7. Experience with denosumab (XGEVA®) for prevention of skeletal-related events in the 10 years after approval.

8. Patient, Caregiver, and Nurse Preferences for Treatments for Bone Metastases from Solid Tumors.

9. Distal Medullary Canal Decompression in Long Stem Hip Replacement in Long Bone Metastasis: Does it Reduce Cardiopulmonary Complications?